HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of parenteral ciprofloxacin with clindamycin-gentamicin in the treatment of pelvic infection.

Abstract
A prospective, randomized study of intravenous followed by oral ciprofloxacin compared with the combination of intravenous clindamycin and gentamicin was conducted in 122 women hospitalized with pelvic infections. Clinical diagnoses included endometritis (97 patients) and uncomplicated pelvic inflammatory disease (25 patients). Treatment successes for endometritis included 42 of 50 (84 percent) patients treated with ciprofloxacin compared with 35 of 47 (75 percent) treated with the clindamycin-gentamicin combination. Treatment successes for acute salpingitis included 10 of 10 (100 percent) treated with ciprofloxacin and 13 of 15 (87 percent) treated with clindamycin-gentamicin. Ciprofloxacin successfully eradicated Chlamydia trachomatis in 11 of 12 patients as did clindamycin-gentamicin in six of seven patients. In this study of pelvic infection, ciprofloxacin demonstrated efficacy comparable with the combination of clindamycin and gentamicin, and is effective against C. trachomatis.
AuthorsJ J Apuzzio, R Stankiewicz, V Ganesh, S Jain, Z Kaminski, D Louria
JournalThe American journal of medicine (Am J Med) Vol. 87 Issue 5A Pg. 148S-151S (Nov 30 1989) ISSN: 0002-9343 [Print] United States
PMID2589359 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Gentamicins
  • Clindamycin
  • Ciprofloxacin
Topics
  • Acute Disease
  • Adult
  • Bacterial Infections (drug therapy)
  • Ciprofloxacin (administration & dosage, therapeutic use)
  • Clindamycin (administration & dosage, therapeutic use)
  • Drug Therapy, Combination (therapeutic use)
  • Endometritis (drug therapy)
  • Female
  • Gentamicins (administration & dosage, therapeutic use)
  • Humans
  • Prospective Studies
  • Random Allocation
  • Salpingitis (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: